CCDC6 and hepatocellular carcinoma: The CCDC6 level was also significantly elevated in patients with HCC from different age groups (21-40 years, 41-60 years, 61-80 years and 81-100 years) and in patients with CCA (41-60 years and 61-80 years; Figure 2E).